Differential regulation of TNF receptor 1 and receptor 2 in adiponectin expression following myocardial ischemia

International Journal of Cardiology

Volumn 168, Issue 3, 2013, Pages 2201-2206

  Wang, Yajing ^a,b   Zhao, Jianli ^a   Zhang, Yanqing ^a   Lau, Wayne Bond ^b   Jiao, Li Yuan ^a   Liu, Baojiang ^a   Yuan, Yuexing ^b   Wang, Xiaoliang ^b   Tao, Ling ^c   Gao, Erhe ^d   Koch, Walter J ^d   Ma, Xin Liang ^b  

^a SHANXI MEDICAL UNIVERSITY   (China)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^d TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adiponectin; Diabetes; Receptor; Tumor necrosis factor

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; ADIPONECTIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; RNA;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME REGULATION; ENZYME REPRESSION; ENZYME SYNTHESIS; GENE DELETION; GENE SILENCING; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; METABOLISM; POLYMERASE CHAIN REACTION;

ADIPONECTIN; ANIMALS; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL ISCHEMIA; POLYMERASE CHAIN REACTION; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RNA;

EID: 84885656829     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.01.222     Document Type: Article

References (30)

1. V.L. Roger, A.S. Go, and D.M. Lloyd-Jones Heart disease and stroke statistics - 2011 update: a report from the American Heart Association Circulation 123 2011 e18 e209
2. Z.V. Wang, and P.E. Scherer Adiponectin, cardiovascular function, and hypertension Hypertension 51 2008 8 14
3. C.C. Smith, and D.M. Yellon Adipocytokines, cardiovascular pathophysiology and myocardial protection Pharmacol Ther 129 2011 206 219
4. B.J. Goldstein, R.G. Scalia, and X.L. Ma Protective vascular and myocardial effects of adiponectin Nat Clin Pract Cardiovasc Med 6 2009 27 35
5. M. Kumada, S. Kihara, and S. Sumitsuji Association of hypoadiponectinemia with coronary artery disease in men Arterioscler Thromb Vasc Biol 23 2003 85 89
6. T. Pischon, C.J. Girman, G.S. Hotamisligil, N. Rifai, F.B. Hu, and E.B. Rimm Plasma adiponectin levels and risk of myocardial infarction in men JAMA 291 2004 1730 1737
7. J. Frystyk, C. Berne, L. Berglund, K. Jensevik, A. Flyvbjerg, and B. Zethelius Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men J Clin Endocrinol Metab 92 2007 571 576
8. S. Kojima, T. Funahashi, and F. Otsuka Future adverse cardiac events can be predicted by persistently low plasma adiponectin concentrations in men and marked reductions of adiponectin in women after acute myocardial infarction Atherosclerosis 194 2006 204 213
9. R. Shibata, Y. Numaguchi, and K. Matsushita Usefulness of adiponectin to predict myocardial salvage following successful reperfusion in patients with acute myocardial infarction Am J Cardiol 101 2008 1712 1715
10. T. Yamauchi, K. Hara, and N. Kubota Dual roles of adiponectin/Acrp30 in vivo as an anti-diabetic and anti-atherogenic adipokine Curr Drug Targets Immune Endocr Metabol Disord 3 2003 243 254
11. A. Higuchi, K. Ohashi, S. Kihara, K. Walsh, and N. Ouchi Adiponectin suppresses pathological microvessel formation in retina through modulation of tumor necrosis factor-{alpha} expression Circ Res 104 2009 1058 1065
12. R. Shibata, K. Sato, and D.R. Pimentel Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms Nat Med 11 2005 1096 1103
13. J. Hector, B. Schwarzloh, and J. Goehring TNF-alpha alters visfatin and adiponectin levels in human fat Horm Metab Res 39 2007 250 255
14. P.A. Kern, G.B. Di Gregorio, T. Lu, N. Rassouli, and G. Ranganathan Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression Diabetes 52 2003 1779 1785
15. N. Komai, Y. Morita, T. Sakuta, A. Kuwabara, and N. Kashihara Anti-tumor necrosis factor therapy increases serum adiponectin levels with the improvement of endothelial dysfunction in patients with rheumatoid arthritis Mod Rheumatol 17 2007 385 390
16. L. Thommesen, and A. Laegreid Distinct differences between TNF receptor 1- and TNF receptor 2-mediated activation of NFkappaB J Biochem Mol Biol 38 2005 281 289
17. Y. Wang, L. Tao, and Y. Yuan Cardioprotective effect of adiponectin is partially mediated by its AMPK-independent antinitrative action Am J Physiol Endocrinol Metab 297 2009 E384 E391
18. D. Faustman, and M. Davis TNF receptor 2 pathway: drug target for autoimmune diseases Nat Rev Drug Discov 9 2010 482 493
19. G.J. Tesz, A. Guilherme, and K.V. Guntur Tumor necrosis factor alpha (TNFalpha) stimulates Map4k4 expression through TNFalpha receptor 1 signaling to c-Jun and activating transcription factor 2 J Biol Chem 282 2007 19302 19312
20. M. Good, F.M. Newell, L.M. Haupt, J.P. Whitehead, L.J. Hutley, and J.B. Prins TNF and TNF receptor expression and insulin sensitivity in human omental and subcutaneous adipose tissue - influence of BMI and adipose distribution Diab Vasc Dis Res 3 2006 26 33
21. J.K. Sethi, H. Xu, K.T. Uysal, S.M. Wiesbrock, L. Scheja, and G.S. Hotamisligil Characterisation of receptor-specific TNFalpha functions in adipocyte cell lines lacking type 1 and 2 TNF receptors FEBS Lett 469 2000 77 82
22. H. Su, W.B. Lau, and X.L. Ma Hypoadiponectinaemia in diabetes mellitus type 2: molecular mechanisms and clinical significance Clin Exp Pharmacol Physiol 38 2011 897 904
23. N. Maeda, M. Takahashi, and T. Funahashi PPAR{gamma} ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein Diabetes 50 2001 2094 2099
24. Y. Higuchi, C.F. McTiernan, C.B. Frye, B.S. McGowan, T.O. Chan, and A.M. Feldman Tumor necrosis factor receptors 1 and 2 differentially regulate survival, cardiac dysfunction, and remodeling in transgenic mice with tumor necrosis factor-alpha-induced cardiomyopathy Circulation 109 2004 1892 1897
25. Y. Monden, T. Kubota, and T. Inoue Tumor necrosis factor-{alpha} is toxic via receptor 1 and protective via receptor 2 in a murine model of myocardial infarction Am J Physiol Heart Circ Physiol 293 2007 H743 H753
26. R. Kishore, T. Tkebuchava, and S.P. Sasi Tumor necrosis factor-alpha signaling via TNFR1/p55 is deleterious whereas TNFR2/p75 signaling is protective in adult infarct myocardium Adv Exp Med Biol 691 2011 433 448
27. T. Hamid, Y. Gu, and R.V. Ortines Divergent tumor necrosis factor receptor-related remodeling responses in heart failure: role of nuclear factor-{kappa}B and inflammatory activation Circulation 119 2009 1386 1397
28. D.A. Goukassian, G. Qin, and C. Dolan Tumor necrosis factor-alpha receptor p75 is required in ischemia-induced neovascularization Circulation 115 2007 752 762
29. M. Liu, L. Zhou, and A. Xu A disulfide-bond A oxidoreductase-like protein (DsbA-L) regulates adiponectin multimerization PNAS 105 2008 18302 18307
30. B.R. Kupchak, I. Garitaonandia, N.Y. Villa, J.L. Smith, and T.J. Lyons Antagonism of human adiponectin receptors and their membrane progesterone receptor paralogs by TNFalpha and a ceramidase inhibitor Biochemistry 48 2009 5504 5506